1. Home
  2. VRDN vs MXL Comparison

VRDN vs MXL Comparison

Compare VRDN & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • MXL
  • Stock Information
  • Founded
  • VRDN 2006
  • MXL 2003
  • Country
  • VRDN United States
  • MXL United States
  • Employees
  • VRDN N/A
  • MXL N/A
  • Industry
  • VRDN Medical Specialities
  • MXL Semiconductors
  • Sector
  • VRDN Health Care
  • MXL Technology
  • Exchange
  • VRDN Nasdaq
  • MXL Nasdaq
  • Market Cap
  • VRDN 1.3B
  • MXL 1.0B
  • IPO Year
  • VRDN N/A
  • MXL 2010
  • Fundamental
  • Price
  • VRDN $14.34
  • MXL $14.22
  • Analyst Decision
  • VRDN Strong Buy
  • MXL Buy
  • Analyst Count
  • VRDN 11
  • MXL 8
  • Target Price
  • VRDN $38.50
  • MXL $20.21
  • AVG Volume (30 Days)
  • VRDN 750.1K
  • MXL 1.1M
  • Earning Date
  • VRDN 08-07-2025
  • MXL 07-23-2025
  • Dividend Yield
  • VRDN N/A
  • MXL N/A
  • EPS Growth
  • VRDN N/A
  • MXL N/A
  • EPS
  • VRDN N/A
  • MXL N/A
  • Revenue
  • VRDN $302,000.00
  • MXL $361,192,000.00
  • Revenue This Year
  • VRDN N/A
  • MXL $24.12
  • Revenue Next Year
  • VRDN $17,102.33
  • MXL $19.30
  • P/E Ratio
  • VRDN N/A
  • MXL N/A
  • Revenue Growth
  • VRDN 4.86
  • MXL N/A
  • 52 Week Low
  • VRDN $9.90
  • MXL $8.35
  • 52 Week High
  • VRDN $27.20
  • MXL $26.59
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 50.32
  • MXL 72.10
  • Support Level
  • VRDN $14.11
  • MXL $12.73
  • Resistance Level
  • VRDN $16.05
  • MXL $13.39
  • Average True Range (ATR)
  • VRDN 0.74
  • MXL 0.52
  • MACD
  • VRDN -0.13
  • MXL 0.17
  • Stochastic Oscillator
  • VRDN 20.18
  • MXL 97.64

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: